Trade Medtronic - MDT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 83.52 |
Open* | 83.78 |
1-Year Change* | 7.25% |
Day's Range* | 83.38 - 83.92 |
52 wk Range | 68.84-92.02 |
Average Volume (10 days) | 6.14M |
Average Volume (3 months) | 134.64M |
Market Cap | 114.74B |
P/E Ratio | 28.03 |
Shares Outstanding | 1.33B |
Revenue | 31.96B |
EPS | 3.08 |
Dividend (Yield %) | 3.19852 |
Beta | 0.79 |
Next Earnings Date | Feb 20, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 15, 2024 | 83.52 | 0.07 | 0.08% | 83.45 | 83.95 | 82.45 |
Mar 14, 2024 | 84.33 | -0.02 | -0.02% | 84.35 | 84.64 | 83.90 |
Mar 13, 2024 | 85.02 | -0.97 | -1.13% | 85.99 | 86.28 | 84.73 |
Mar 12, 2024 | 85.67 | 1.00 | 1.18% | 84.67 | 86.03 | 84.35 |
Mar 11, 2024 | 85.42 | 0.88 | 1.04% | 84.54 | 85.53 | 84.44 |
Mar 8, 2024 | 85.05 | 0.06 | 0.07% | 84.99 | 86.20 | 84.61 |
Mar 7, 2024 | 85.09 | -0.81 | -0.94% | 85.90 | 86.37 | 84.60 |
Mar 6, 2024 | 85.51 | 1.29 | 1.53% | 84.22 | 85.74 | 84.22 |
Mar 5, 2024 | 84.52 | -0.80 | -0.94% | 85.32 | 85.71 | 84.22 |
Mar 4, 2024 | 84.99 | 1.64 | 1.97% | 83.35 | 85.05 | 83.08 |
Mar 1, 2024 | 83.54 | 0.98 | 1.19% | 82.56 | 83.79 | 82.51 |
Feb 29, 2024 | 83.31 | 0.18 | 0.22% | 83.13 | 83.71 | 82.70 |
Feb 28, 2024 | 83.29 | -0.22 | -0.26% | 83.51 | 83.76 | 83.17 |
Feb 27, 2024 | 83.77 | 0.43 | 0.52% | 83.34 | 84.12 | 82.97 |
Feb 26, 2024 | 83.61 | -1.63 | -1.91% | 85.24 | 85.47 | 83.42 |
Feb 23, 2024 | 85.59 | 0.43 | 0.50% | 85.16 | 85.89 | 84.73 |
Feb 22, 2024 | 84.99 | -0.52 | -0.61% | 85.51 | 85.81 | 84.43 |
Feb 21, 2024 | 85.85 | 0.37 | 0.43% | 85.48 | 86.36 | 84.78 |
Feb 20, 2024 | 85.78 | -0.41 | -0.48% | 86.19 | 86.99 | 82.45 |
Feb 16, 2024 | 84.37 | 0.32 | 0.38% | 84.05 | 85.68 | 83.98 |
Medtronic Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, March 21, 2024 | ||
Time (UTC) 12:00 | Country IE
| Event Medtronic PLC Medtronic PLCForecast -Previous - |
Time (UTC) 12:00 | Country IE
| Event Medtronic PLC Medtronic PLCForecast -Previous - |
Time (UTC) 12:00 | Country IE
| Event Medtronic PLC Medtronic PLCForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 31227 | 31686 | 30117 | 28913 | 30557 |
Revenue | 31227 | 31686 | 30117 | 28913 | 30557 |
Cost of Revenue, Total | 10622 | 9971 | 10355 | 9269 | 9064 |
Gross Profit | 20605 | 21715 | 19762 | 19644 | 21493 |
Total Operating Expense | 25795 | 25934 | 25941 | 24535 | 24774 |
Selling/General/Admin. Expenses, Total | 10242 | 10135 | 9776 | 9875 | 10232 |
Research & Development | 2696 | 2746 | 2493 | 2331 | 2330 |
Depreciation / Amortization | 1698 | 1733 | 1783 | 1756 | 1764 |
Interest Expense (Income) - Net Operating | -117 | -224 | |||
Unusual Expense (Income) | 914 | 1154 | 1219 | 1303 | 1342 |
Other Operating Expenses, Total | -377 | 195 | 315 | 118 | 266 |
Operating Income | 5432 | 5752 | 4176 | 4378 | 5783 |
Interest Income (Expense), Net Non-Operating | -164 | -541 | -425 | -379 | -676 |
Other, Net | 96 | 306 | 144 | 56 | 90 |
Net Income Before Taxes | 5364 | 5517 | 3895 | 4055 | 5197 |
Net Income After Taxes | 3784 | 5061 | 3524 | 4743 | 4662 |
Minority Interest | -26 | -22 | -24 | -17 | -19 |
Net Income Before Extra. Items | 3758 | 5039 | 3500 | 4726 | 4643 |
Net Income | 3758 | 5039 | 3606 | 4789 | 4631 |
Income Available to Common Excl. Extra. Items | 3758 | 5039 | 3500 | 4726 | 4643 |
Income Available to Common Incl. Extra. Items | 3758 | 5039 | 3606 | 4789 | 4631 |
Diluted Net Income | 3758 | 5039 | 3606 | 4789 | 4631 |
Diluted Weighted Average Shares | 1332.8 | 1351.4 | 1354 | 1351.1 | 1357.5 |
Diluted EPS Excluding Extraordinary Items | 2.81963 | 3.72873 | 2.58493 | 3.49789 | 3.42026 |
Dividends per Share - Common Stock Primary Issue | 2.72 | 2.52 | 2.32 | 2.16 | 2 |
Diluted Normalized EPS | 2.93517 | 4.58931 | 3.55835 | 4.13123 | 4.31147 |
Total Extraordinary Items | 106 | 63 | -12 | ||
Total Adjustments to Net Income | 0 |
Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | |
---|---|---|---|---|---|
Total revenue | 8545 | 7727 | 7585 | 7371 | 8089 |
Revenue | 8545 | 7727 | 7585 | 7371 | 8089 |
Cost of Revenue, Total | 2949 | 2663 | 2516 | 2497 | 2565 |
Gross Profit | 5596 | 5064 | 5069 | 4874 | 5524 |
Total Operating Expense | 6980 | 6335 | 6185 | 6306 | 6418 |
Selling/General/Admin. Expenses, Total | 2568 | 2575 | 2572 | 2526 | 2570 |
Research & Development | 641 | 688 | 676 | 692 | 652 |
Depreciation / Amortization | 423 | 431 | 421 | 423 | 435 |
Unusual Expense (Income) | 446 | 128 | 114 | 236 | 53 |
Other Operating Expenses, Total | -47 | -150 | -114 | -68 | 143 |
Operating Income | 1565 | 1392 | 1400 | 1065 | 1671 |
Interest Income (Expense), Net Non-Operating | -36 | -41 | -33 | -24 | -167 |
Other, Net | 22 | 24 | 28 | 3 | 98 |
Net Income Before Taxes | 1551 | 1375 | 1395 | 1044 | 1602 |
Net Income After Taxes | 1189 | 1229 | 436 | 932 | 1492 |
Minority Interest | -9 | -6 | -8 | -2 | -6 |
Net Income Before Extra. Items | 1180 | 1223 | 428 | 930 | 1486 |
Net Income | 1180 | 1223 | 428 | 930 | 1486 |
Income Available to Common Excl. Extra. Items | 1179 | 1222 | 427 | 929 | 1485 |
Income Available to Common Incl. Extra. Items | 1179 | 1222 | 427 | 929 | 1485 |
Diluted Net Income | 1179 | 1222 | 427 | 929 | 1485 |
Diluted Weighted Average Shares | 1332.8 | 1332 | 1332 | 1329.4 | 1343.9 |
Diluted EPS Excluding Extraordinary Items | 0.8846 | 0.91742 | 0.32057 | 0.69881 | 1.10499 |
Dividends per Share - Common Stock Primary Issue | 0.68 | 0.68 | 0.68 | 0.68 | 0.63 |
Diluted Normalized EPS | 1.15621 | 1.03904 | -0.16141 | 0.86054 | 1.05737 |
Total Adjustments to Net Income | -1 | -1 | -1 | -1 | -1 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 21675 | 23059 | 22548 | 22031 | 21967 |
Cash and Short Term Investments | 7959 | 10573 | 10817 | 10948 | 9848 |
Cash & Equivalents | 1543 | 3714 | 3593 | 4140 | 4393 |
Short Term Investments | 6416 | 6859 | 7224 | 6808 | 5455 |
Total Receivables, Net | 5998 | 5551 | 5462 | 4645 | 6222 |
Accounts Receivable - Trade, Net | 5998 | 5551 | 5462 | 4645 | 6222 |
Total Inventory | 5293 | 4616 | 4313 | 4229 | 3753 |
Other Current Assets, Total | 2425 | 2319 | 1956 | 2209 | 2144 |
Total Assets | 90948 | 90981 | 93083 | 90689 | 89694 |
Property/Plant/Equipment, Total - Net | 6610 | 6267 | 6219 | 5755 | 4675 |
Property/Plant/Equipment, Total - Gross | 15103 | 14219 | 13698 | 12571 | 10920 |
Accumulated Depreciation, Total | -8493 | -7952 | -7479 | -6816 | -6245 |
Goodwill, Net | 41425 | 40502 | 41961 | 39841 | 39959 |
Intangibles, Net | 14844 | 15595 | 17740 | 19063 | 20560 |
Long Term Investments | 1607 | 881 | 687 | 480 | 372 |
Other Long Term Assets, Total | 4787 | 4677 | 3928 | 3519 | 2161 |
Total Current Liabilities | 9051 | 12394 | 8509 | 10366 | 8472 |
Accounts Payable | 2662 | 2276 | 2106 | 1996 | 1953 |
Accrued Expenses | 5216 | 5367 | 5681 | 4839 | 4885 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 20 | 3742 | 11 | 2776 | 838 |
Other Current Liabilities, Total | 1153 | 1009 | 711 | 755 | 796 |
Total Liabilities | 39465 | 38430 | 41655 | 39952 | 39603 |
Total Long Term Debt | 24344 | 20372 | 26378 | 22021 | 24486 |
Long Term Debt | 24287 | 20316 | 26316 | 21976 | 24476 |
Capital Lease Obligations | 57 | 56 | 62 | 45 | 10 |
Deferred Income Tax | 708 | 884 | 1028 | 1174 | 1278 |
Minority Interest | 182 | 171 | 174 | 135 | 121 |
Other Liabilities, Total | 5180 | 4609 | 5566 | 6256 | 5246 |
Total Equity | 51483 | 52551 | 51428 | 50737 | 50091 |
Common Stock | 0.1331 | 0.13307 | 0.13454 | 0.13411 | 0.13407 |
Additional Paid-In Capital | 24590 | 24566 | 26319 | 26165 | 26532 |
Retained Earnings (Accumulated Deficit) | 30392 | 30250 | 28594 | 28132 | 26270 |
Unrealized Gain (Loss) | -258 | -209 | 92 | 0 | -45 |
Other Equity, Total | -3241.13 | -2056.13 | -3577.13 | -3560.13 | -2666.13 |
Total Liabilities & Shareholders’ Equity | 90948 | 90981 | 93083 | 90689 | 89694 |
Total Common Shares Outstanding | 1330.81 | 1330.74 | 1345.4 | 1341.07 | 1340.7 |
Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | |
---|---|---|---|---|---|
Total Current Assets | 21869 | 21675 | 25364 | 25398 | 22135 |
Cash and Short Term Investments | 7876 | 7959 | 11137 | 11430 | 8873 |
Cash & Equivalents | 1339 | 1543 | 4521 | 4828 | 2140 |
Short Term Investments | 6537 | 6416 | 6616 | 6602 | 6733 |
Total Receivables, Net | 5806 | 5998 | 5887 | 5626 | 5308 |
Accounts Receivable - Trade, Net | 5806 | 5998 | 5887 | 5626 | 5308 |
Total Inventory | 5668 | 5293 | 5375 | 5055 | 4809 |
Other Current Assets, Total | 2519 | 2425 | 2965 | 3287 | 3145 |
Total Assets | 90776 | 90948 | 94134 | 93241 | 89914 |
Property/Plant/Equipment, Total - Net | 5665 | 5569 | 5437 | 5298 | 5281 |
Property/Plant/Equipment, Total - Gross | 14062 | 13926 | 13497 | 13323 | |
Accumulated Depreciation, Total | -8493 | -8489 | -8199 | -8043 | |
Goodwill, Net | 41436 | 41425 | 41565 | 40417 | 40324 |
Intangibles, Net | 14434 | 14844 | 15265 | 15655 | 15775 |
Long Term Investments | 1569 | 1076 | 980 | 912 | 880 |
Other Long Term Assets, Total | 5803 | 6359 | 5523 | 5561 | 5519 |
Total Current Liabilities | 9047 | 9051 | 14422 | 14465 | 14049 |
Accounts Payable | 2239 | 2662 | 2209 | 2198 | 2180 |
Accrued Expenses | 4942 | 5530 | 5637 | 5752 | 5589 |
Notes Payable/Short Term Debt | 500 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 19 | 20 | 5918 | 5864 | 5729 |
Other Current Liabilities, Total | 1347 | 839 | 658 | 651 | 551 |
Total Liabilities | 39598 | 39465 | 42693 | 41361 | 37241 |
Total Long Term Debt | 24463 | 24344 | 22210 | 20753 | 17481 |
Long Term Debt | 24406 | 24287 | 22155 | 20698 | 17423 |
Capital Lease Obligations | 57 | 57 | 55 | 55 | 58 |
Deferred Income Tax | 687 | 708 | 747 | 871 | 899 |
Minority Interest | 188 | 182 | 177 | 177 | 170 |
Other Liabilities, Total | 5213 | 5180 | 5137 | 5095 | 4642 |
Total Equity | 51178 | 51483 | 51441 | 51880 | 52673 |
Common Stock | 0.13304 | 0.1331 | 0.13303 | 0.1331 | 0.1329 |
Additional Paid-In Capital | 24587 | 24590 | 24513 | 24442 | 24335 |
Retained Earnings (Accumulated Deficit) | 30265 | 30392 | 30117 | 29799 | 30276 |
Unrealized Gain (Loss) | -277 | -258 | -285 | -392 | -225 |
Other Equity, Total | -3397.13 | -3241.13 | -2904.13 | -1969.13 | -1713.13 |
Total Liabilities & Shareholders’ Equity | 90776 | 90948 | 94134 | 93241 | 89914 |
Total Common Shares Outstanding | 1330.5 | 1330.81 | 1330.38 | 1330.15 | 1329.28 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | 3784 | 5062 | 3630 | 4806 | 4650 |
Cash From Operating Activities | 6039 | 7347 | 6240 | 7234 | 7007 |
Cash From Operating Activities | 2697 | 2707 | 2702 | 2663 | 2659 |
Deferred Taxes | -226 | -604 | -422 | -1315 | -304 |
Non-Cash Items | 751 | 1070 | 1031 | 1019 | 1082 |
Cash Taxes Paid | 1548 | 996 | 1250 | 878 | 1558 |
Cash Interest Paid | 606 | 540 | 582 | 643 | 973 |
Changes in Working Capital | -967 | -888 | -701 | 61 | -1080 |
Cash From Investing Activities | -3493 | -1659 | -2866 | -3203 | -774 |
Capital Expenditures | -1459 | -1368 | -1355 | -1213 | -1134 |
Other Investing Cash Flow Items, Total | -2034 | -291 | -1511 | -1990 | 360 |
Cash From Financing Activities | -4960 | -5336 | -4136 | -4198 | -5431 |
Financing Cash Flow Items | -409 | 163 | -268 | -81 | 14 |
Total Cash Dividends Paid | -3616 | -3383 | -3120 | -2894 | -2693 |
Issuance (Retirement) of Stock, Net | -337 | -2115 | -178 | -664 | -1885 |
Issuance (Retirement) of Debt, Net | -598 | -1 | -570 | -559 | -867 |
Foreign Exchange Effects | 243 | -231 | 215 | -86 | -78 |
Net Change in Cash | -2171 | 121 | -547 | -253 | 724 |
Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 3784 | 2595 | 1367 | 931 | 5062 |
Cash From Operating Activities | 6039 | 3579 | 2004 | 1083 | 7347 |
Cash From Operating Activities | 2697 | 2018 | 1339 | 668 | 2707 |
Deferred Taxes | -226 | -78 | -92 | -18 | -604 |
Non-Cash Items | 751 | 569 | 441 | 251 | 1070 |
Cash Taxes Paid | 1548 | 1314 | 821 | 260 | 996 |
Cash Interest Paid | 606 | 262 | 234 | 68 | 540 |
Changes in Working Capital | -967 | -1525 | -1051 | -749 | -888 |
Cash From Investing Activities | -3493 | -3018 | -2731 | -1585 | -1659 |
Capital Expenditures | -1459 | -1081 | -749 | -426 | -1368 |
Other Investing Cash Flow Items, Total | -2034 | -1937 | -1982 | -1159 | -291 |
Cash From Financing Activities | -4960 | -70 | 2064 | -950 | -5336 |
Financing Cash Flow Items | -409 | -276 | 443 | 273 | 163 |
Total Cash Dividends Paid | -3616 | -2711 | -1807 | -903 | -3383 |
Issuance (Retirement) of Stock, Net | -337 | -339 | -324 | -293 | -2115 |
Issuance (Retirement) of Debt, Net | -598 | 3256 | 3752 | -27 | -1 |
Foreign Exchange Effects | 243 | 317 | -223 | -122 | -231 |
Net Change in Cash | -2171 | 808 | 1114 | -1574 | 121 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4134 | 125248443 | 256379 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.1344 | 68314497 | -1141975 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.5205 | 60146861 | 175765 | 2023-06-30 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 2.5858 | 34405154 | -246464 | 2023-06-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.367 | 31493771 | 1475241 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9255 | 25619149 | -575779 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.84 | 24481730 | -5463619 | 2023-06-30 | LOW |
Managed Account Advisors LLC | Investment Advisor | 1.2314 | 16384219 | -578461 | 2023-06-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.176 | 15647195 | 1275304 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.1108 | 14779508 | 6305779 | 2023-06-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.0457 | 13913148 | -552216 | 2023-06-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.0325 | 13737300 | -1841351 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0273 | 13668496 | 1004940 | 2022-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 1.0184 | 13549505 | 3650117 | 2023-06-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.9795 | 13032292 | -74836 | 2023-06-30 | LOW |
Wells Fargo Advisors | Research Firm | 0.9788 | 13023211 | 130387 | 2023-06-30 | LOW |
Sanders Capital, LLC | Investment Advisor | 0.9216 | 12261659 | -804527 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.8199 | 10908629 | 2271 | 2023-06-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7677 | 10214379 | 518483 | 2023-06-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.7617 | 10135213 | -168108 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Medtronic Company profile
Medtronic (MDT) is a global medical device manufacturer, headquartered in Dublin. Established in 1949, Medtronic managed to grow into the world’s biggest provider of medical services and solutions through a number of acquisitions. The company has six principal departments that create devices and equipment for the treatment of chronic diseases. The company’s main business units focus on diabetes, cardiac diseases management, and surgical technologies. Medtronic trades on the New York Stock Exchange (NYSE) and is featured in the S&P100 Index. Download the Capital.com app to get regular updates on the Medtronic share price data.Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
DUBLIN
DUBLIN
IE
Income Statement
- Annual
- Quarterly
News
Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?
UK banks will be in the spotlight in the week ahead as the European earnings season continues
16:38, 16 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com